| Discharge Regimen (w/ or w/o Steroids Use) | All | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CyA | Tac | CyA+ MMF | Tac+ MMF | CyA+ Aza | Tac+ Aza | Siro+ MMF | CyA+ Siro | Tac+ Siro | Other | ||
| Functioning Graft with Immunosuppression Info at Discharge | 91 | 266 | 2,955 | 5,306 | 221 | 118 | 78 | 8 | 76 | 754 | 9,873 |
| % of All Regimens | 0.9% | 2.7% | 29.9% | 53.7% | 2.2% | 1.2% | 0.8% | 0.1% | 0.8% | 7.6% | 100.0% |
| Induction Drug | 8.8% | 7.1% | 5.3% | 4.9% | 9.5% | 6.8% | 7.7% | 37.5% | 5.3% | 16.6% | 6.2% |
| Atgam/NRATG/NRATS | |||||||||||
| OKT3 | 2.2% | 0.0% | 2.6% | 1.8% | 28.1% | 5.9% | 1.3% | 0.0% | 3.9% | 6.9% | 3.0% |
| Thymoglobulin | 9.9% | 11.3% | 14.0% | 18.8% | 20.4% | 38.1% | 21.8% | 12.5% | 55.3% | 25.2% | 18.1% |
| Zenapax | 4.4% | 1.1% | 21.1% | 10.6% | 3.2% | 2.5% | 9.0% | 12.5% | 0.0% | 31.0% | 14.7% |
| Simulect | 13.2% | 8.6% | 13.1% | 14.9% | 5.0% | 3.4% | 12.8% | 25.0% | 1.3% | 21.6% | 14.2% |
| Campath | 1.1% | 7.9% | 0.1% | 3.0% | 0.5% | 0.0% | 6.4% | 0.0% | 0.0% | 2.9% | 2.2% |
| No Induction Drugs Recorded | 64.8% | 65.0% | 45.7% | 49.7% | 34.4% | 43.2% | 43.6% | 37.5% | 35.5% | 47.2% | 48.3% |